SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-338750
Filing Date
2017-11-09
Accepted
2017-11-09 16:06:08
Documents
64
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d461840d10q.htm 10-Q 598234
2 EX-31.1 d461840dex311.htm EX-31.1 6192
3 EX-31.2 d461840dex312.htm EX-31.2 6181
4 EX-32.1 d461840dex321.htm EX-32.1 6243
  Complete submission text file 0001193125-17-338750.txt   3388103

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20170930.xml EX-101.INS 559176
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20170930.xsd EX-101.SCH 46218
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20170930_cal.xml EX-101.CAL 59059
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20170930_def.xml EX-101.DEF 131670
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20170930_lab.xml EX-101.LAB 341609
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20170930_pre.xml EX-101.PRE 247835
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 171190796
SIC: 2834 Pharmaceutical Preparations